Creative Medical Technology Holdings (CELZ) stock price, revenue, and financials

Creative Medical Technology Holdings market cap is $999.4 k, and annual revenue was $165.50 k in FY 2019

$999.4 K

CELZ Mkt cap, 25-Sept-2020

$27.9 K

Creative Medical Technology Holdings Revenue Q2, 2020
Creative Medical Technology Holdings Gross profit (Q2, 2020)17.1 K
Creative Medical Technology Holdings Gross profit margin (Q2, 2020), %61.3%
Creative Medical Technology Holdings Net income (Q2, 2020)-1.8 M
Creative Medical Technology Holdings EBIT (Q2, 2020)-214.3 K
Creative Medical Technology Holdings Cash, 30-Jun-202037 K
Creative Medical Technology Holdings EV2 M

Creative Medical Technology Holdings Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

4.8k124.4k165.5k

Cost of goods sold

8.0k70.4k45.5k

Gross profit

(3.2k)54.0k120.0k

Gross profit Margin, %

(67%)43%73%

R&D expense

85.3k260.1k96.6k

General and administrative expense

1.8k850.0675.0750.01.0k665.0k898.5k1.1m1.2m

Operating expense total

1.8k850.07.8k9.3k11.0k750.3k1.2m1.2m1.3m

Depreciation and amortization

9.4k16.0k21.1k27.0k

EBIT

(19.8k)(20.1k)(20.1k)(19.4k)(20.8k)(766.1k)(1.2m)(1.1m)(1.1m)

EBIT margin, %

(24538%)(896%)(683%)

Interest expense

1.7k697.01.5m12.5m

Pre tax profit

(24.1k)(25.6k)(27.3k)(28.0k)(30.8k)(13.7m)(8.5m)

Net Income

(24.1k)(25.6k)(27.3k)(28.0k)(30.8k)(766.1k)(2.7m)(13.7m)(8.5m)

Creative Medical Technology Holdings Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.1k781.0374.0954.0216.0221.9k13.7k304.1k88.6k

Accounts Receivable

4.8k9.6k5.6k

Prepaid Expenses

2.0k

Current Assets

3.1k1.6k374.0954.0216.0221.9k18.5k313.7k94.2k

Total Assets

3.1k1.6k374.0954.0216.0322.5k203.1k477.2k530.8k

Accounts Payable

7.9k10.0k8.1k10.2k17.1k66.4k237.6k331.8k320.8k

Short-term debt

100.0k1.1m

Current Liabilities

75.3k99.3k125.4k154.0k157.8k453.9k2.4m4.5m8.6m

Total Debt

100.0k1.1m

Total Liabilities

480.3k2.4m4.5m8.6m

Common Stock

18.1k18.1k18.1k18.1k18.1k114.8k902.7k22.5k

Preferred Stock

Additional Paid-in Capital

154.2k154.2k154.2k154.2k154.2k503.8k1.1m12.2m17.5m

Retained Earnings

(244.5k)(270.0k)(297.3k)(325.3k)(356.1k)(766.6k)(3.4m)(17.1m)(25.6m)

Total Equity

(72.2k)(97.7k)(125.0k)(153.0k)(183.8k)(2.2m)(4.0m)(8.1m)

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0.5 x

Financial Leverage

0 x0 x0 x0 x0 x-0.1 x-0.1 x-0.1 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

400.01.2k631.0531.0756.0597.0403.0398.01.3k1.3k1.3k583.0641.0741.0216.025.8k33.5k98.1k104.4k21.2k102.3k100.5k172.8k419.5k204.1k158.2k38.3k37.0k

Accounts Receivable

9.6k4.8k14.0k163.01.0k24.5k8.4k1.4k

Prepaid Expenses

1.0k394.01.2k

Inventories

2.8k1.2k

Current Assets

400.04.2k1.6k531.01.2k1.8k403.0398.01.3k1.3k1.3k583.0641.0741.0216.033.5k98.1k104.4k21.2k111.9k105.3k186.8k419.6k205.1k182.7k49.5k39.6k

Total Assets

400.04.2k1.6k531.01.2k1.8k403.0398.01.3k1.3k1.3k583.0641.0741.0216.0121.7k136.7k196.1k299.6k211.2k291.3k279.4k355.6k577.9k358.0k330.4k469.3k442.9k

Accounts Payable

3.4k7.7k7.8k8.3k9.8k6.7k8.1k12.0k10.4k11.3k12.5k11.3k12.7k19.6k25.6k44.8k96.9k53.2k157.1k233.4k272.8k242.8k342.8k320.4k323.8k386.6k380.6k

Short-term debt

19.8k15.7k1.0m1.0m

Current Liabilities

61.2k69.6k82.8k86.8k92.9k109.6k113.9k119.4k136.3k142.1k147.8k162.9k304.0k446.0k468.9k1.3m1.3m8.2m10.9m7.7m4.2m3.0m3.9m3.7m4.6m

Total Debt

19.8k15.7k1.0m1.0m

Total Liabilities

169.2k175.6k171.0k373.1k471.9k495.8k1.3m1.3m8.2m10.9m7.7m4.2m3.0m3.9m3.7m4.6m

Common Stock

18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k18.1k100.0k101.3k106.0k106.3k106.3k400.3k677.1k784.2k1.0m1.2m2.1m85.8k245.3k

Additional Paid-in Capital

154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k154.2k6.2k135.6k604.2k767.4k769.1k2.7m6.2m10.9m13.3m14.1m14.7m18.6m19.2m

Retained Earnings

(233.1k)(237.7k)(253.5k)(258.5k)(264.1k)(280.1k)(285.8k)(291.3k)(307.3k)(313.1k)(318.8k)(334.6k)(340.9k)(347.2k)(361.2k)(357.6k)(572.1k)(1.0m)(1.9m)(1.9m)(11.0m)(17.4m)(19.0m)(17.9m)(18.0m)(20.4m)(21.8m)(23.7m)

Total Equity

(60.8k)(65.4k)(81.2k)531.0(91.8k)(107.8k)(113.5k)(119.0k)(135.0k)(140.8k)(146.5k)(162.3k)(168.6k)(174.9k)(188.9k)(251.4k)(335.2k)(299.7k)(1.0m)(1.1m)(7.9m)(10.6m)(7.4m)(3.6m)(2.6m)(3.6m)(3.2m)(4.2m)

Debt to Equity Ratio

-0.1 x0 x

Debt to Assets Ratio

0.2 x0.1 x

Financial Leverage

0 x-0.1 x0 x1 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x-0.5 x-0.4 x-0.7 x-0.3 x-0.2 x0 x0 x0 x-0.2 x-0.1 x-0.1 x-0.1 x-0.1 x

Creative Medical Technology Holdings Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(24.1k)(25.6k)(27.3k)(28.0k)(30.8k)(766.1k)(2.7m)(13.7m)(8.5m)

Depreciation and Amortization

9.4k16.0k21.1k27.0k

Accounts Receivable

(4.8k)(4.8k)4.0k

Accounts Payable

7.9k(1.9k)2.1k6.9k22.6k171.2k94.8k(11.1k)

Cash From Operating Activities

(14.0k)(22.9k)(17.3k)(14.6k)445.2k(889.6k)(1.1m)(1.2m)

Cash From Investing Activities

(10.0k)

Long-term Borrowings

(313.4k)

Cash From Financing Activities

14.7k22.5k17.9k13.9k677.0k681.5k1.3m997.7k

Net Change in Cash

691.0(407.0)580.0(738.0)221.8k(208.2k)290.4k(215.4k)

Interest Paid

1.7k697.011.1k6.7k18.2k

Creative Medical Technology Holdings Ratios

USDQ2, 2011